Induction of a physiologically active brain-derived neurotrophic factor in the infant rat brain by peripheral administration of 4-methylcatechol

被引:17
作者
Fukumitsu, H
Sometani, A
Ohmiya, M
Nitta, A
Nomoto, H
Furukawa, Y
Furukawa, S
机构
[1] Gifu Pharmaceut Univ, Mol Biol Lab, Gifu 5028585, Japan
[2] Aichi Bunkyo Womens Coll, Aichi 4928521, Japan
关键词
brain-derived neurotrophic factor; 4-methylcatechol; calbindin D-28; immunostaining; in situ hybridization;
D O I
10.1016/S0304-3940(99)00691-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Effects of 4-methylcatechol (4MC), a known potent stimulator of nerve growth factor (NGF) synthesis, on expression of brain-derived neurotrophic factor (BDNF) mRNA and BDNF-like immunoreactivity (BDNF-LI) was investigated in infant rat brains. A single intraperitoneal administration of 4MC caused transient increases in the levels of BDNF mRNA and BDNF-LI in neurons of the cerebral cortex from 1 to 3 h and 3 to 12 h, respectively, after the injection. Repetitive injections of 4MC to newborn rats (12-h intervals for 10 days) caused a marked and dose-dependent elevation of the level of BDNF mRNA in the whole brain besides elevating the number of cells containing calbindin D-28 and enhancing its immunoreactive intensity in the pyriform cortex and hippocampus. These findings demonstrate that 4MC stimulates de novo synthesis of BDNF in the infant rat brain, resulting in acceleration of the developmental expression of calbindin D-28. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 20 条
[1]  
Barde Y A, 1994, Prog Clin Biol Res, V390, P45
[2]   BRAIN-DERIVED NEUROTROPHIC FACTOR PROTECTS AGAINST ISCHEMIC CELL-DAMAGE IN RAT HIPPOCAMPUS [J].
BECK, T ;
LINDHOLM, D ;
CASTREN, E ;
WREE, A .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (04) :689-692
[3]  
Furukawa S, 1998, NEUROSCIENCE, V82, P653
[4]  
FURUKAWA Y, 1986, J BIOL CHEM, V261, P6039
[5]   Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma [J].
Hicks, RR ;
Numan, S ;
Dhillon, HS ;
Prasad, MR ;
Seroogy, KB .
MOLECULAR BRAIN RESEARCH, 1997, 48 (02) :401-406
[6]  
KAECHI K, 1995, J PHARMACOL EXP THER, V272, P1300
[7]  
KAECHI K, 1993, J PHARMACOL EXP THER, V264, P321
[8]   Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat [J].
Kim, KS ;
Wass, CA ;
Cross, AS .
EXPERIMENTAL NEUROLOGY, 1997, 145 (01) :253-257
[9]   Synthesis and evaluation of brain-targeted chemical delivery systems for the neurotrophomodulator 4-methylcatechol [J].
Kourounakis, A ;
Bodor, N ;
Simpkins, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (01) :1-9
[10]   DEVELOPMENTAL AND AGE-DEPENDENT CHANGES OF 28-KDA CALBINDIN-D IN THE CENTRAL NERVOUS-TISSUE DETERMINED WITH A SENSITIVE IMMUNOASSAY METHOD [J].
KUROBE, N ;
INAGUMA, Y ;
SHINOHARA, H ;
SEMBA, R ;
INAGAKI, T ;
KATO, K .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (01) :128-134